National Research Corporation (NASDAQ:NRCIA) major shareholder K/I/E/Trust Under Agreement 3/ sold 109,000 shares of the company’s stock in a transaction on Thursday, October 19th. The shares were sold at an average price of $37.00, for a total transaction of $4,033,000.00. Following the completion of the transaction, the insider now owns 5,656,900 shares of the company’s stock, valued at approximately $209,305,300. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

National Research Corporation (NASDAQ:NRCIA) traded down 1.99% during trading on Monday, reaching $36.95. 21,941 shares of the company’s stock traded hands. The stock has a market capitalization of $897.85 million, a P/E ratio of 40.69 and a beta of 1.72. The stock has a 50-day moving average price of $36.31 and a 200 day moving average price of $29.01. National Research Corporation has a 1-year low of $14.35 and a 1-year high of $41.99.

The firm also recently announced a quarterly dividend, which was paid on Friday, October 13th. Shareholders of record on Friday, September 29th were given a $0.10 dividend. This represents a $0.40 annualized dividend and a yield of 1.06%. The ex-dividend date of this dividend was Thursday, September 28th. National Research Corporation’s dividend payout ratio is 76.92%.

TRADEMARK VIOLATION NOTICE: “National Research Corporation (NRCIA) Major Shareholder Sells $4,033,000.00 in Stock” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/10/23/national-research-corporation-nrcia-major-shareholder-sells-4033000-00-in-stock.html.

Separately, Zacks Investment Research upgraded shares of National Research Corporation from a “hold” rating to a “buy” rating and set a $33.00 price objective for the company in a research note on Saturday, August 5th.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Strs Ohio boosted its holdings in shares of National Research Corporation by 49.6% during the 3rd quarter. Strs Ohio now owns 18,100 shares of the business services provider’s stock worth $682,000 after buying an additional 6,000 shares during the period. The Manufacturers Life Insurance Company boosted its holdings in shares of National Research Corporation by 252.1% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 9,090 shares of the business services provider’s stock worth $244,000 after buying an additional 6,508 shares during the period. State Street Corp boosted its holdings in shares of National Research Corporation by 12.2% during the 2nd quarter. State Street Corp now owns 157,748 shares of the business services provider’s stock worth $4,241,000 after buying an additional 17,163 shares during the period. Goldman Sachs Group Inc. boosted its holdings in shares of National Research Corporation by 55.6% during the 2nd quarter. Goldman Sachs Group Inc. now owns 19,467 shares of the business services provider’s stock worth $524,000 after buying an additional 6,955 shares during the period. Finally, Hillsdale Investment Management Inc. bought a new stake in shares of National Research Corporation during the 2nd quarter worth $729,000. 28.80% of the stock is owned by institutional investors and hedge funds.

National Research Corporation Company Profile

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect.

Receive News & Stock Ratings for National Research Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corporation and related stocks with our FREE daily email newsletter.